Thoraxklinik Heidelberg

Thoraxklinik Heidelberg

Thoraxklinik Heidelberg

a brief profile

Thoraxklinik Heidelberg is one of the largest specialized hospitals for the treatment of lung diseases in Europe and is a subsidiary of Heidelberg University Hospital. The certified institution enjoys an over 100-year history and draws on the pooled expertise of highly qualified specialists. Every year, more than 2,300 surgical procedures of the thorax (chest) and respiratory organs are performed here. Thoraxklinik Heidelberg treats around 10,500 in-patients and some 30,100 outpatients per year.

Since 2009, Thoraxklinik Heidelberg has been certified as a Lung Cancer Center by the German Cancer Society. In close cooperation with the German Cancer Research Center (DKFZ) and as a partner of the German Center for Lung Research (DZL) and a founding member of the National Center for Tumor Diseases (NCT), the Thoraxklinik is actively engaged in science and research. In line with this, cutting-edge treatment concepts and diagnostic methods are applied at the Thoraxklinik to benefit the patients.

Univ.-Prof. Dr. med. Felix Herth

Medical Director

Portrait of Prof. Dr. med. Felix Herth

Location

Röntgenstraße 1
69126 Heidelberg


Set of specification

core competencies and disease focuses

  1. Diagnosis and treatment of pulmonary emphysema and rare lung diseases
  2. Robot-assisted thorax surgery (RATS)
  3. Long-term ventilation and weaning
  4. Diagnosis and treatment of bronchial carcinoma, pleural mesothelioma and thymic tumors
  5. Precision oncology (combining state-of-the-art molecular diagnostics and targeted therapy)

 


Key figures that are unique in national/international comparison

  • 3,000 interventions for lung volume reduction
  • More than 100 long-term ventilation weaning treatments per year
  • Oncological treatment: more than 3,000 patients per year
  • More than 2,500 lung operations including uniportal procedures and VATS lobectomies and RATS lobectomies

Innovative medical technology

  • All types of navigation procedures
  • All interventional procedures

Research groups with international expertise

  • Emphysema research group: Co-development of four methods
  • Rare lung disease research group: First-in-human studies ongoing
  • Weaning research group: In charge of national studies
  • Exploration of resistance
  • Biomarker assessment
  • German Center for Lung Research (DZL) member

Internationally recognized certifications and/or distinctions

KTQ certified

Cooperation for transparency and quality in the health care sector GmbH

Lung cancer Society

German Cancer Association

Quality assurance for process quality

German Sleep Society

Weaning center

German Respiratory Society

Certified training “Basic qualification in home mechanical ventilation”

German Interdisciplinary Association of Home Mechanical Ventilation, DIGAB

Certified Cystic Fibrosis Center

Cystic Fibrosis Institute

Current international collaborations

  • Earl A Chiles Research Institute (EACRI)

    Prof. B. Fox, Influence of immune cell infiltrates on the prognosis of patients with non-small cell lung cancer, Molecular and Tumor Immunology Laboratory, Portland, Oregon, USA

    Go to EACRI
  • Shanghai Chest Hospital, China

    Go to Shanghai Chest Hospital
  • Military Hospital No.1 Beijing, China

Special indicators of interdisciplinary collaboration

Interdisciplinary consultation is employed in the treatment of all diseases

Research focuses

Molecular tumor diagnostics

Ongoing studies with international relevance

Over 20 ongoing studies with international relevance

 

Publications with international reach

Over 1000 English publications with international reach

Go to PubMed

Unique selling points at the international level

Lung volume reduction